Copper reduction by copper binding proteins and its relation to neurodegenerative diseases

BioMetals

Volumn 16, Issue 1, 2003, Pages 91-98

  Opazo, Carlos ^a   Inés Barría, María ^a   Ruiz, Francisca H ^a   Inestrosa, Nibaldo C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Alzheimer's Disease; Amyloid precursor protein; Amyloid peptide; Copper reduction; Prion protein

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIOXIDANT; BINDING PROTEIN; COPPER; COPPER BINDING PROTEIN; CYSTEINE; HISTIDINE; PRION PROTEIN; REACTIVE OXYGEN METABOLITE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; CELL MEMBRANE; COMPLEX FORMATION; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; HUMAN; OXIDATIVE STRESS; PRION DISEASE; PROTEIN PROTEIN INTERACTION; REDUCTION;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN PRECURSOR; CARRIER PROTEINS; COPPER; CREUTZFELDT-JAKOB SYNDROME; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PRIONS; ZINC;

EID: 0037355742     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020795422185     Document Type: Conference Paper

References (45)

1. Alvarez A, Opazo C, Alarcón R et al. 1997 Acetyl cholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils. J Mol Biol, 272, 348-361.
2. Atwood CS, Moir RD, Huang X et al. 1998 Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273, 12817-12826.
3. Atwood CS, Scarpa RC, Huang X et al. 2000 Characterization of copper interactions with Alzheimer amyloid β peptides: identification of an attomolar-affinity copper binding site on amyloid β 1-42. J Neurochem 75, 1219-1233.
4. Brown DR, Clive C, Haswell SJ. 2001 Antioxidant activity related to copper binding of native prion protein. J Neurochem 76, 69-76.
5. Bush AI. 2000 Metals and neuroscience. Curr Opin Chem Biol 4, 184-191.
6. Castagne V, Gautschi M, Lefevre K et al. 1999 Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Prog Neurobiol 59, 397-423.
7. Curtain CC, Ali F, Volitakis I et al. 2001 Alzheimer's disease amyloid-β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem, 276, 20466-20473.
8. Davies KJA, Delsignore MA, LIN SW. 1987 Protein damage and degradation by oxygen radicals. II. Modification of amino acids. J Biol Chem, 262, 9902-9907.
9. Dykalov SI, Vitek MP, Maples KR et al. 1999 Amyloid peptides do not form peptide derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides. J Biol Chem 274, 9392-9939.
10. Dyrks T, Dyrks E, Hartmann T, et al. 1992 Amyloidogenicity of βA4-bearing amyloid protein precursor fragments by metal-catayzed oxidation. J Biol Chem 267, 18210-18217.
11. Estevez AG, Crow JP, Sampson JB et al. 1999 Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286, 2498-2500.
12. Frederickson CJ. 1989. Neurobiology of zinc and zinc-containing neurons. Int Rev Neurobiol 31, 145-238.
13. Frederickson CJ, Bush AI. 2001 Synaptically released zinc: physiological functions and pathological effects. Biometals 14, 353-366.
14. Hassett R, Kosman DJ. 1995 Evidence for Cu(II) reduction as a component of copper uptake by Saccharomyces cerevisiae. J Biol Chem, 270, 128-134.
15. Halliwell B, Gutteridge JMC. 1990 Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186, 1-85.
16. 67copper. Synapse 2, 412-415.
17. Hensley K, Carney JM, Mattson MP et al. 1994 A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci USA, 91, 3270-3274.
18. Hesse L, Beher D, Masters CL et al. 1994 The βA4 amyloid precursor protein binding to copper. FEBS Lett 349, 109-116.
19. Huang X, Atwood CS, Hartshorn MA et al. 1999a The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38, 7609-7616.
20. Huang X, Cuajungco MP, Atwood CS et al. 1999b Cu(II) potentiation of Alzheimer Aβ neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem 274, 37111-37116.
21. Inestrosa, NC, Alvarez A, Perez CD et al. 1996 Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16, 881-891.
22. Iversen LL, Mortishire-Smith J, Pollack SJ et al. 1995 The toxicity in vitro of β-amyloid protein. Biochem J 311, 1-16.
23. Jackson GS, Murray I, Hosszu LLP et al. 2001 Location and properties of metal-binding sites on the human prion protein. Proc Natl Acad Sci USA 98, 8531-8535
24. Lovell, MA, Robertson JD, Teesdale WJ et al. 1998 Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158, 47-52.
25. Miranda MS, Opazo C, Larrondo LF et al. 2000 The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer's disease. Prog Neurobiol 62, 633-648.
26. Multhaup G, Schlicksupp A, Hesse L et al. 1996 The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper(I). Science 271, 1406-1409.
27. Multhaup G, Ruppert T, Schlicksupp A et al. 1998 Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. Biochemistry 37, 7224-7230.
28. Nunomura A, Perry G, Aliev G, et al. 2001 Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60, 759-767.
29. Nuñez MT, Garate MA, Arredondo M et al. 2000 The cellular mechanisms of body iron homeostasis. Biol Res 33, 133-142.
30. O'Halloran TV, Culotta VC. 2000 Metallochaperones, an intracellular shuttle service for metal ions. J Biol Chem 275, 25057-25060.
31. Opazo C, Ruiz FH, Inestrosa NC. 2000 Amyloid-β-peptide reduces copper(II) to copper(I) independent of its aggregation state. Biol Res 33, 125-131.
32. Praticò D, Uryu K, Leight S et al. 2001 Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21, 4183-4187.
33. Prusiner SB (1991) Molecular biology of prion diseases. Science 252, 1515-1522.
34. Rae TD, Schmidt PJ, Pufhal RA et al. 1999 Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 284, 805-808.
35. Rosenzweig AC, O'Halloran TV. 2000 Structure and chemistry of the copper chaperone proteins. Curr Opin Chem Biol 4, 140-147.
36. Ruiz FH, Gonzalez, M, Bodini M et al. 1999 Cysteine 144 is a key residue in the copper reduction by the β-amyloid precursor protein. J Neurochem 73, 1288-1292.
37. Ruiz FH, Silva E, Inestrosa NC. 2000 The N-terminal tandem repeat region of human prion protein reduces copper: role of tryptophan residues. Biochem Biophys Res Commun 269, 491-495.
38. Sayre LM, Perry G, Smith MA. 1999 Redox metals and neurodegenerative disease. Curr Opin Chem Biol 3, 220-225.
39. Selkoe DJ. 1997 Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275, 630-631.
40. Smith MA, Perry G, Richey PL et al. 1996 Oxidative damage in Alzheimer's disease. Nature 382, 120-121.
41. Smith MA, Hirai K, Hsiao K et al. 1998 Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70, 2212-2215.
42. Stahl N, Borchelt DR, Hsiao K et al. 1987 Scrapie prion protein cantains a phosphatidylinositol glycolipid. Cell 51, 229-240.
43. Stockel J, Safar J, Wallace AC et al. 1998 Prion protein selectively binds Copper (II) ions. Biochemistry 37, 7185-7193.
44. Wadsworth JDF, Hill AF, Joiner S et al. 1999 Strain-specific prionprotein conformation determined by metal ions. Nat Cell Biol 1, 55-59.
45. Zhou B, Gitschier J. 1997 hCTR1: a human gene for copper uptake identified by complementation in yeast. Proc Natl Acad Sci USA. 94, 7481-7486.